Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:35 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Phase not reported / not applicableCompletedOBSERVATIONAL
Start: 2009-02. Completion: 2010-03 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
desmopressin (drug) — also listed as: Nocturin®
Where the study takes place — 140 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Investigational Site - Pauwelsstraße 30 Aachen, Germany Site recruitment: Not reported
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Start: 2011-04. Completion: Not reported (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Oxytocin (drug) — also listed as: syntocinon
Arginine Vasopressin (drug)
placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Hadassah University Medical Organization Jerusalem, Jerusalem, Israel Site recruitment: Recruiting
Start: 2009-02. Completion: 2011-02 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Desmotabs (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Klinikum der Johannes Gutenberg-Universität Mainz, Studienzentrum Neurologie, Langenbeckstr. 1, 55131 Mainz Mainz, Germany Site recruitment: Not reported
Start: 2009-07. Completion: 2010-12 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Lixivaptan (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2007-06. Completion: 2007-12 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
M0002 (drug)
Placebo (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2006-12. Completion: 2010-04 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
pantoloc 40 mg (drug) — also listed as: pantoloc, a proton pump inhibitor
somatostatin or terlipressin (drug) — also listed as: somatostatin and terlipressin are vasoconstrictors.
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2009-01. Completion: 2020-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Lifestyle (behavioral) — also listed as: Stress Management Therapy (SMT)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Department of Otolaryngology, Osaka University, School of Medicine Suita, Osaka, Japan Site recruitment: Recruiting
Start: 2004-03. Completion: 2009-01 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
removal of ovarian vessels (procedure)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Tripler Army Medical Center Honolulu, Hawaii, United States Site recruitment: Not reported
Start: 2008-11. Completion: 2010-02 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
continuous infusion of terlipressin (drug)
Arginine vasopressin (drug)
terlipressin bolus administration (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Departement of Anesthesiology and Intensive Care Rome, I, Italy Site recruitment: Not reported
Start: 2003-07. Completion: 2003-08 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Desmopressin Acetate 0.2 mg Tablets (drug)
DDAVP® 0.2 mg Tablets (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
MDS Pharma Sercives Saint-Laurent, Quebec, Canada Site recruitment: Not reported
Start: 2004-04. Completion: 2005-12 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Desmopressin (drug) — also listed as: Minirin
Where the study takes place — 6 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Keimyung University School of Medicine Daegu, South Korea Site recruitment: Not reported
College of Medicine Inha University Inchon, South Korea Site recruitment: Not reported
Pusan National University Hospital Pusan, South Korea Site recruitment: Not reported
Asan Medical Center Seoul, South Korea Site recruitment: Not reported
Korea University Anam Hospital Seoul, South Korea Site recruitment: Not reported
Seoul National University College of Medicine Seoul, South Korea Site recruitment: Not reported
Hypothermia Induced Impairment of Primary Haemostasis
Sponsor
The University of Hong Kong
Countries with listed sites
China
Registry dates and results
Start: 2009-06. Completion: 2011-06 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
desmopressin (drug)
desmopressin (drug)
desmopressin (drug)
placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The University of Hong Kong Hong Kong, Hong Kong, China Site recruitment: Not reported
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Australia · Belgium · Brazil · Canada · France · Germany · Hong Kong · Hungary · Russia · Switzerland · United States
Registry dates and results
Start: 2005-07. Completion: 2007-08 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
SR121463B (drug)
Where the study takes place — 11 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States Site recruitment: Not reported
Sanofi-Aventis Administrative Office Macquarie Park, Australia Site recruitment: Not reported
Sanofi-Aventis Administrative Office Diegem, Belgium Site recruitment: Not reported
Sanofi-Aventis Administrative Office São Paulo, Brazil Site recruitment: Not reported
sanofi-aventis Canada Laval, Canada Site recruitment: Not reported
Sanofi-Aventis Administrative Office Paris, France Site recruitment: Not reported
Sanofi-Aventis Administrative Office Berlin, Germany Site recruitment: Not reported
Sanofi-Aventis Administrative Office Causeway Bay, Hong Kong Site recruitment: Not reported
Sanofi-Aventis Administrative Office Budapest, Hungary Site recruitment: Not reported
Sanofi-Aventis Administrative Office Moscow, Russia Site recruitment: Not reported
Sanofi-Aventis Administrative Office Geneva, Switzerland Site recruitment: Not reported
Start: 2003-10. Completion: 2007-05 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Desmopressin (drug)
blood transfusion (biological)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Mount Sinai School of Medicine New York, New York, United States Site recruitment: Not reported
Belgium · Brazil · Canada · Croatia · Germany · Hong Kong · Hungary · Netherlands · Portugal · Spain · United States
Registry dates and results
Start: 2004-05. Completion: 2007-09 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
SR121463B (drug)
Where the study takes place — 11 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States Site recruitment: Not reported
Sanofi-Aventis Administrative Office Diegem, Belgium Site recruitment: Not reported
Sanofi-Aventis Administrative Office São Paulo, Brazil Site recruitment: Not reported
Sanofi-Aventis Administrative Office Laval, Canada Site recruitment: Not reported
Sanofi-Aventis Administrative Office Zagreb, Croatia Site recruitment: Not reported
Sanofi-Aventis Administrative Office Berlin, Germany Site recruitment: Not reported
Sanofi-Aventis Administrative Office Causeway Bay, Hong Kong Site recruitment: Not reported
Sanofi-Aventis Administrative Office Budapest, Hungary Site recruitment: Not reported
Sanofi-Aventis Administrative Office Gouda, Netherlands Site recruitment: Not reported
Sanofi-Aventis Administrative Office Porto Salvo, Portugal Site recruitment: Not reported
Sanofi-Aventis Administrative Office Barcelona, Spain Site recruitment: Not reported
Start: 2006-01. Completion: 2010-01 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Icodextrin (dialysate) (drug)
Physioneal (dialysate) 1.36% and 2.27% (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Deparment of Renal Medicine, Skejby Hospital Aarhus, Denmark Site recruitment: Not reported
Start: 2008-11. Completion: 2009-07 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
terlipressin (drug) — also listed as: glypressin
terlipressin (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Asaf Harofeh MC Zrifin, Israel Site recruitment: Not reported
Start: 2006-08. Completion: 2008-08 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Terlipressin (drug) — also listed as: Novapressin
Terlipressin & then Dummy (drug) — also listed as: Novapressin
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The Aga Khan University Hospital Karachi, Sindh, Pakistan Site recruitment: Not reported
Start: 2006-11. Completion: 2008-03 (may be estimated). No results posted in this registry response.
Products and interventions (0)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University Hospital Basel Basel, Canton of Basel-City, Switzerland Site recruitment: Not reported
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.